Skip to search formSkip to main contentSkip to account menu

EM 523

Known as: EM-523, EM523L, Erythromycin, 8,9-didehydro-9-deoxo-6-deoxy-6,9-epoxy- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Tachyphylaxis may have contributed to the failure of the motilide ABT-229 [N-ethyl, N-methyl 4′′ deoxy erythromycin (EM)-B… 
1997
1997
OBJECTIVE To evaluate the effect of the erythromycin derivative EM523L on gastric emptying and postprandial insulin requirement… 
1995
1994
1994
EM523L, a newly developed erythromycin derivative, has a powerful motilin-like biologic effect and no antibacterial activity. In… 
Highly Cited
1991
Highly Cited
1991
1990
1990
The effect of EM-523 [de(N-methyl)-N-ethyl-8,9-anhydroerythromycin A 6,9-hemiacetal], an erythromycin derivative, on preparations… 
Highly Cited
1989
Highly Cited
1989
The effect of an erythromycin derivative, EM-523, on gastrointestinal motility was investigated in conscious dogs and compared…